MedTech Industry in APAC

It is predicted that over 60% of the world’s population will be living in Asia by 2030 with one in four people over the age of 60 or older.

Driven by higher healthcare costs, an aging demographic, a rise in chronic diseases and a growing population of ever discerning healthcare consumers, the healthcare market in Asia Pacific is on track to achieve unprecedented growth. By 2022, the value of the APAC MedTech industry is expected to climb at a CAGR of 8.8 % to 157 billion USD.

This has created an abundance of opportunities for the healthcare industry to tap into, with innovations and products that are specific to the diseases and chronic health issues that affect those living in Asia Pacific.